Henry Schein, Inc. (HSIC)
NASDAQ: HSIC · Real-Time Price · USD
69.60
+1.39 (2.04%)
At close: Aug 22, 2025, 4:00 PM
69.60
0.00 (0.00%)
After-hours: Aug 22, 2025, 4:00 PM EDT
Henry Schein Revenue
Henry Schein had revenue of $3.24B in the quarter ending June 28, 2025, with 3.32% growth. This brings the company's revenue in the last twelve months to $12.77B, up 2.29% year-over-year. In the year 2024, Henry Schein had annual revenue of $12.67B with 2.71% growth.
Revenue (ttm)
$12.77B
Revenue Growth
+2.29%
P/S Ratio
0.66
Revenue / Employee
$510,920
Employees
25,000
Market Cap
8.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 28, 2024 | 12.67B | 334.00M | 2.71% |
Dec 30, 2023 | 12.34B | -308.00M | -2.44% |
Dec 31, 2022 | 12.65B | 246.00M | 1.98% |
Dec 25, 2021 | 12.40B | 2.28B | 22.55% |
Dec 26, 2020 | 10.12B | 133.20M | 1.33% |
Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 26, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
HSIC News
- 10 hours ago - Henry Schein to Participate in Upcoming Investor Conferences in September - Business Wire
- 3 days ago - Henry Schein's 28th Annual ‘Back to School' Program Supports Students Worldwide - Business Wire
- 8 days ago - Henry Schein: The Case For An Upgrade From Hold To Buy - Seeking Alpha
- 17 days ago - Henry Schein, Inc. (HSIC) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Henry Schein's 2025 Outlook Hinges On Strong Second-Half Execution - Benzinga
- 17 days ago - Henry Schein falls after missing quarterly profit estimates - Reuters
- 17 days ago - Henry Schein Reports Second Quarter 2025 Financial Results - Business Wire
- 22 days ago - Henry Schein: Still Bullish Even As Shares Languish - Seeking Alpha